Related Experiment Video
Updated: Jun 21, 2026
07:13
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
The new lung cancer staging system.
Frank C Detterbeck1, Daniel J Boffa1, Lynn T Tanoue2
1Thoracic Surgery, Yale University School of Medicine, New Haven, CT.
Chest
|July 9, 2009
Summary
The International Association for the Study of Lung Cancer revised the lung cancer staging system. New TNM descriptors and stage groupings for non-small cell lung cancer are recommended based on extensive international data.
Area of Science:
- Oncology
- Thoracic Surgery
- Pulmonary Medicine
Background:
- The lung cancer staging system requires updates to reflect current knowledge.
- Accurate staging is crucial for treatment planning and prognosis in non-small cell lung cancer (NSCLC).
Purpose of the Study:
- To review the recommendations from the IASLC International Staging Committee for the revised lung cancer staging system.
- To outline the new TNM descriptors and stage groupings for NSCLC.
Main Methods:
- Development of an international lung cancer database.
- Extensive analysis of a large patient population and their prognoses.
- Formation of the IASLC International Staging Committee to review data and formulate recommendations.
Main Results:
- The IASLC has proposed revised definitions for TNM descriptors.
- New stage groupings for non-small cell lung cancer have been established.
- Recommendations are based on a comprehensive international dataset.
Conclusions:
- The revised IASLC staging system provides updated TNM definitions and stage groupings for NSCLC.
- These revisions aim to improve the accuracy of lung cancer staging.
- The updated system will guide clinical practice and future research in lung cancer.
